Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C390326-20 20 µg (0.2 mg/ml) $371 
LS-C390326-100 100 µg (0.2 mg/ml) $574 
HLA-DR Antibody - SDS-PAGE Analysis of Purified, BSA-Free HLA-DR Antibody (clone 169-1B5.2). Confirmation of Integrity and Purity of the Antibody.

Monoclonal Mouse anti‑Human HLA‑DR Antibody (clone 169‑1B5.2, IF) LS‑C390326

Monoclonal Mouse anti‑Human HLA‑DR Antibody (clone 169‑1B5.2, IF) LS‑C390326

Antibody:
HLA-DR Mouse anti-Human Monoclonal (169-1B5.2) Antibody
Application:
IF, Flo
Reactivity:
Human, Bovine
Format:
Unconjugated, Unmodified
Price
Catalog Number
$371
LS-C390326-20
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
HLA-DR Mouse anti-Human Monoclonal (169-1B5.2) Antibody
Application:
IF, Flo
Reactivity:
Human, Bovine
Format:
Unconjugated, Unmodified

Specifications

Description
HLA-DR antibody LS-C390326 is an unconjugated mouse monoclonal antibody to HLA-DR from human. It is reactive with human and bovine. Validated for Flow and IF. Cited in 1 publication.
Target
Human HLA-DR
Host
Mouse
Reactivity
Human, Bovine (tested or 100% immunogen sequence identity)
Clonality
IgG2b,k Monoclonal
Clone
169-1B5.2
Conjugations
Unconjugated
Purification
Protein G purified
Modifications
Unmodified. Also available Azide-free, BSA-free, Ready-to-Use.
Immunogen
Human peripheral blood leukocytes were used as the immunogen for the HLA-DR antibody.
Specificity
Human HLA-DR.
Applications
  • Immunofluorescence (0.5 - 1 µg/ml)
  • Flow Cytometry (0.5 - 1 µg/10E6 cells)
Usage
This antibody detects a monomorphic general framework determinant of HLA-DR Class II antigen. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kDa alpha (heavy) chain and a 28kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts. Optimal dilution of the HLA-DR antibody should be determined by the researcher.
Presentation
1X PBS, 0.1 mg/ml BSA, 0.05% sodium azide
Storage
Store at 2°C to 8°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee

LSBio Ratings

HLA-DR Antibody (clone 169-1B5.2) for IF/Immunofluorescence, Flow LS-C390326 has an LSBio Rating of
Publications (4)

Publications (1)

Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro. Rombach-Riegraf V, Karle AC, Wolf B, Sordé L, Koepke S, Gottlieb S, Krieg J, Djidja MC, Baban A, Spindeldreher S, Koulov AV, Kiessling A. PloS one. 2014 9:e86322. (Flo; Human)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 12/27/2024